Literature DB >> 16961266

Effect of truncated-ApoE4 overexpression on tau phosphorylation in cultured N2a cells.

Jie Zhou1, Juan Chen, Youmei Feng.   

Abstract

The carboxyl-terminal amino acids 272-299-truncated apoE4 (delta272-299) is the main fragments of apoE4 hydrolysate in neurons. The effects of truncated-ApoE4 (delta272-299) overexpression on tau phosphorylation in cultured N2a cells were investigated. The truncated-apoE4 (delta272-299) cDNA was subcloned into pEGFP-c3 to form recombinant pEGFP-T-apoE4. pEGFP-c3, pEGFP-T-apoE4 and pEGFP-apoE4 were transfected into N2a cells respectively by lipofectamine 2000 method. After 24--48 h, tau phosphorylation was detected by Western blot assay and glycogen synthase kinase-3 (GSK-3) activity by using GSK-3 activity assay. The results showed that the overexpression of both full length-apoE4 and truncated apoE4 fragments in N2a cells induced a dramatic increase in phosphorylation of tau at Ser202 sites and the activation of GSK-3 as compared with untransfected cells, most significantly in the cells transfected with pEGFP-T-apoE4 (P < 0.05). It was concluded that in vitro overexpression of truncated-ApoE4 (delta272-299) can result in tau hyperphosphorylation in N2a cells by activating GSK-3, suggesting truncated-ApoE4 (delta272-299) might contribute the pathogenesis of Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961266     DOI: 10.1007/bf02829548

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

Review 1.  Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.

Authors:  A M Fagan; D M Holtzman
Journal:  Microsc Res Tech       Date:  2000-08-15       Impact factor: 2.769

2.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Authors:  Y Huang; X Q Liu; T Wyss-Coray; W J Brecht; D A Sanan; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.

Authors:  Shiming Ye; Yadong Huang; Karin Müllendorff; Liming Dong; Gretchen Giedt; Elaine C Meng; Fred E Cohen; Irwin D Kuntz; Karl H Weisgraber; Robert W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

4.  Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain.

Authors:  J J Pei; T Tanaka; Y C Tung; E Braak; K Iqbal; I Grundke-Iqbal
Journal:  J Neuropathol Exp Neurol       Date:  1997-01       Impact factor: 3.685

Review 5.  Tau protein and the neurofibrillary pathology of Alzheimer's disease.

Authors:  M Goedert
Journal:  Trends Neurosci       Date:  1993-11       Impact factor: 13.837

6.  Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination.

Authors:  Hans H Bock; Yves Jossin; Pingsheng Liu; Eckart Förster; Petra May; André M Goffinet; Joachim Herz
Journal:  J Biol Chem       Date:  2003-07-25       Impact factor: 5.157

Review 7.  The molecular and cellular biology of tau.

Authors:  K S Kosik
Journal:  Brain Pathol       Date:  1993-01       Impact factor: 6.508

8.  Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.

Authors:  A Cedazo-Mínguez; B O Popescu; J M Blanco-Millán; S Akterin; J-J Pei; B Winblad; R F Cowburn
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

9.  Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content.

Authors:  Xianlin Han; Hua Cheng; John D Fryer; Anne M Fagan; David M Holtzman
Journal:  J Biol Chem       Date:  2002-12-24       Impact factor: 5.157

  9 in total
  4 in total

1.  A meta-analysis of mood stabilizers for Alzheimer's disease.

Authors:  Haibing Xiao; Ying Su; Xu Cao; Shenggang Sun; Zhihou Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

2.  Genetic discoveries in AD using CSF amyloid and tau.

Authors:  Carlos Cruchaga; Mark T W Ebbert; John S K Kauwe
Journal:  Curr Genet Med Rep       Date:  2014-03-01

3.  The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice.

Authors:  Alvina W M To; Elena M Ribe; Tsu Tshen Chuang; Joern E Schroeder; Simon Lovestone
Journal:  PLoS One       Date:  2011-02-10       Impact factor: 3.240

4.  GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

Authors:  Carlos Cruchaga; John S K Kauwe; Oscar Harari; Sheng Chih Jin; Yefei Cai; Celeste M Karch; Bruno A Benitez; Amanda T Jeng; Tara Skorupa; David Carrell; Sarah Bertelsen; Matthew Bailey; David McKean; Joshua M Shulman; Philip L De Jager; Lori Chibnik; David A Bennett; Steve E Arnold; Denise Harold; Rebecca Sims; Amy Gerrish; Julie Williams; Vivianna M Van Deerlin; Virginia M-Y Lee; Leslie M Shaw; John Q Trojanowski; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Elaine R Peskind; Douglas Galasko; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Neuron       Date:  2013-04-04       Impact factor: 17.173

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.